ResMed Inc. stock research
FY2026 Q3
ResMed (RMD) Gross Margin — Quarter Ended Mar 31, 2026
Revenue was stable compared to the prior quarter, while gross profit increased and cost of revenue decreased, resulting in a higher gross margin. Compared to the same quarter last year, revenue and gross profit were higher, cost of revenue was higher, and gross margin improved.
Gross margin takeaway
Quarter ended Mar 31, 2026 · FY2026 Q3
Revenue was stable compared to the prior quarter, while gross profit increased and cost of revenue decreased, resulting in a higher gross margin. Compared to the same quarter last year, revenue and gross profit were higher, cost of revenue was higher, and gross margin improved.
- Gross margin improved sequentially and year-over-year, driven by a combination of higher gross profit and a lower cost of revenue relative to revenue in the current quarter.
- Compared to the immediately preceding quarter, gross margin was higher, with gross profit higher and cost of revenue lower. Compared to the same quarter one year earlier, gross margin was higher, with both gross profit and cost of revenue higher.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
62.2%
Gross profit
$891.0M
Revenue
$1.4B
Cost of revenue
$540.4M
Quarter-over-quarter change
+0.5 pts
Year-over-year change
+2.9 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Jun 30, 2025 | $1.3B | $820.1M | $527.9M | 60.8% |
| Sep 30, 2025 | $1.3B | $820.8M | $514.8M | 61.5% |
| Dec 31, 2025 | $1.4B | $878.7M | $544.1M | 61.8% |
| Mar 31, 2026 | $1.4B | $891.0M | $540.4M | 62.2% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Dec 31, 2025
+0.5 pts
Year-over-year change
Mar 31, 2025
+2.9 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
Gross margin improved sequentially and year-over-year, driven by a combination of higher gross profit and a lower cost of revenue relative to revenue in the current quarter.
Compared to the immediately preceding quarter, gross margin was higher, with gross profit higher and cost of revenue lower. Compared to the same quarter one year earlier, gross margin was higher, with both gross profit and cost of revenue higher.
Monitor the trend in cost of revenue relative to revenue, as a lower cost of revenue contributed to the gross margin improvement this quarter.
Peer context
Latest available gross margins for related public companies.
| Company | Gross margin |
|---|---|
| ResMed Inc. (RMD) | 62.2% |